// App-Quantinova.ai

P4-01-09 : Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer

Researchers

Presenter

  • De Laere B

Principal Investigators

  • Peeters DJE

  • Roberto SPeter VBPeter VDA

  • Luc DY

  • Steven VLJ

Medical Centers

  • Catholic University of Leuven, Leuven, Vlaams-Brabant, Belgium

  • CORE Faculty of Medicine and Health Sciences University of Antwerp, Antwerpen, BelgiumGZA Sint-Augustinus, Wilrijk, Antwerpen, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

  • Somatostatin

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved